---
title: "FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295303046.md"
description: "Halper Sadeh LLC is investigating whether Forte Biosciences (FBRX) obtained a fair price for shareholders in its $77/share cash sale to argenx. The firm alleges potential breaches of fiduciary duty and securities laws, citing concerns over conflicted sales processes and inadequate disclosures. Shareholders are encouraged to contact the law firm to discuss their rights and options regarding the transaction."
datetime: "2026-08-08T14:01:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295303046.md)
  - [en](https://longbridge.com/en/news/295303046.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295303046.md)
generator: "portal-rs"
---

# FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders

**FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders**

***Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.*** 

***The proposed transaction may contain terms that could limit superior competing offers.*** 

***Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation.* *We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.*** 

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Forte Biosciences, Inc. (NASDAQ: FBRX) to argenx for $77.00 per share in cash. 

Halper Sadeh encourages Forte shareholders to **click here to learn more about their rights and options**or contact Daniel Sadeh or Zachary Halper **free of charge** at (212) 763-0060 or **sadeh@halpersadeh.com** or **zhalper@halpersadeh.com**. 

The investigation concerns whether Forte and its board of directors violated the federal securities laws and/or breached their fiduciary duties by failing to: (1) obtain the best possible price for Forte shareholders; (2) conduct a fair sales process free of any conflicts of interests; and (3) disclose all material information for Forte shareholders to evaluate the transaction. 

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief and benefits. 

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. 

Attorney Advertising. Prior results do not guarantee a similar outcome. 

Halper Sadeh LLC  
One World Trade Center  
85th Floor  
New York, NY 10007  
Daniel Sadeh, Esq.  
Zachary Halper, Esq.  
(212) 763-0060  
sadeh@halpersadeh.com  
zhalper@halpersadeh.com  
https://www.halpersadeh.com 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260808586427/en/

### Related Stocks

- [FBRX.US](https://longbridge.com/en/quote/FBRX.US.md)
- [ARGX.US](https://longbridge.com/en/quote/ARGX.US.md)
- [34962G208.US](https://longbridge.com/en/quote/34962G208.US.md)

## Related News & Research

- [Forte Biosciences (NASDAQ:FBRX) Sees Strong Trading Volume  - What's Next?](https://longbridge.com/en/news/296380566.md)
- [Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX](https://longbridge.com/en/news/295559644.md)
- [argenx (ENXTBR:ARGX) Hits A Phase 3 Win, Is The Upside Fully Priced?](https://longbridge.com/en/news/296529685.md)
- [Execution Risks Threaten Forte Biosciences–argenx Merger and Shareholder Value](https://longbridge.com/en/news/295896111.md)
- [$100 Invested In argenx 5 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/296119451.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**